First to file Generic 1% Propofol for
EMEA Submission was Successfully Delivered using Hospital ICU setup.
We Support Pharmaceuticals to
Perform Complex Bioequivalence Studies with 100% Regulatory Approvals.
Delivered Complex Iron Sucrose Study for USFDA & help client to become first Generic Company.
Australian Regulatory Authority
Accepted Justification and Safety Rational
for change of salt from succinate to Oxalate for desvelafaxine.